News
Study to evaluate the efficacy and safety of fosmanogepix in adults with invasive mold infectionsStudy completion expected in Q1 2028 Allschwil, Switzerland, July 29, 2025 ...
Decentralized Clinical Trials (DCTs) are transforming how we collect clinical data, but this evolution brings unprecedented challenges in data quality, complexity, and integration.
A research project led by the Ineos Oxford Institute for antimicrobial research (IOI) to study the cause and impact of ...
3d
News Medical on MSNMassey becomes first U.S. site to enroll patients in global Phase 2a trial of first-in-class therapy for T-cell lymphomaVCU Massey Comprehensive Cancer Center is the first site in the United States to be activated in a global Phase 2a clinical ...
TherVacB, a novel therapeutic vaccine for chronic hepatitis B developed under the leadership of Helmholtz Munich, has entered its first clinical trial in patients. Following a successful phase 1a ...
4d
IFLScience on MSN"Groundbreaking" Obesity Treatment That Turns Up The Heat On Fat Cells Passes Phase I Clinical TrialsThe new drug forces fat cells to produce more energy and doesn't impact appetite or muscle mass, unlike some existing ...
18h
GlobalData on MSNFilament Health to supply psilocybin for two Phase II studiesFilament Health has collaborated with UCL to provide its botanical psilocybin drug candidate, PEX010, for two Phase II research studies.
Study to evaluate the efficacy and safety of fosmanogepix in adults with invasive mold infectionsStudy completion expected in ...
Durham-based TruTechnologies has secured a strategic growth investment from LLR Partners to accelerate the expansion of its real-time clinical trial oversight solutions and fuel the next phase of ...
A team of Toronto researchers has received Health Canada approval to conduct clinical trials for a novel class of ...
New findings confirm that partial-breast and reduced-dose radiotherapy effectively treat low-risk early-stage breast cancer ...
TherVacB, a therapeutic vaccine for chronic hepatitis B, has entered its first clinical trial in patients. The first patient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results